Results 11 to 20 of about 1,662 (181)

Effect of single subconjunctival injection of bevacizumab on primary pterygium: clinical, histopathological and immunohistochemical study [PDF]

open access: yesInternational Journal of Ophthalmology, 2018
AIM: To evaluate the effect (clinically, histopathologically and immunohistochemically) and safety of a single intra-pterygium injection of bevacizumab.
Tarek A Mohamed   +3 more
doaj   +4 more sources

The Effect of Subconjunctival Bevacizumab on Angiogenesis in Rabbit Model [PDF]

open access: yesFolia Medica Indonesiana, 2021
The wound healing process is major cause of glaucoma surgery failure and enhances the incapability of controlling the IOP. This aim of study was to evaluate the angiogenesis effect of Bevacizumab injection on the amount and density of blood vessels in ...
Nurwasis Nurwasis   +3 more
doaj   +2 more sources

Efficacy of Subconjunctival Bevacizumab Injections before and after Surgical Excision in Preventing Pterygium Recurrence [PDF]

open access: yesJournal of Ophthalmology, 2017
Purpose. To evaluate the efficacy of subconjunctival bevacizumab injections, before and after surgical excision with bare sclera technique, in preventing postoperative pterygium recurrence. Material and Methods.
Raffaele Nuzzi, Federico Tridico
doaj   +2 more sources

Efficiency and safety of subconjunctival injection of anti-VEGF agent – bevacizumab – in treating dry eye

open access: yesDrug Design, Development and Therapy, 2015
Xiaodan Jiang,* Huibin Lv,* Weiqiang Qiu, Ziyuan Liu, Xuemin Li, Wei Wang Department of Ophthalmology, Peking University Third Hospital, Beijing, People’s Republic of China *These authors contributed equally as first authors Purpose: Dry ...
Jiang X   +5 more
doaj   +1 more source

Efficiency of subconjunctival bevacizumab on pterygium

open access: yesZdravniški Vestnik, 2012
Background: To evaluate the effect and complications of subconjunctival bevacizumab (Avastin ®) on primary and recurrent pterygium. Methods: This prospective study included sixteen patients with pterygium, who received subconjunctival injection of
Alenka Lavrič, Brigita Drnovšek Olup
doaj   +1 more source

To evaluate the efficacy of subconjunctival bevacizumab injection in vascular pterygium before surgical excision in preventing recurrence comparing with bare sclera technique

open access: yesJournal of Clinical Ophthalmology and Research
Introduction: Despite the growing body of evidence supporting the efficacy of subconjunctival bevacizumab injection, questions remain regarding its comparative effectiveness against conventional surgical techniques.
Nusrat Shaheen   +4 more
doaj   +2 more sources

Immediate effect of intravitreal injection of bevacizumab on intraocular pressure

open access: yesClinical Ophthalmology, 2014
Ricardo Lemos-Reis,1 Nuno Moreira-Gonçalves,1 António B Melo,1 Ângela M Carneiro,1,2 Fernando M Falcão-Reis1,2 1Department of Ophthalmology of Hospital de São João, Porto, Portugal; 2Department of Sense Organs ...
Lemos-Reis R   +4 more
doaj   +1 more source

Preoperative subconjunctival combined injection of bevacizumab and mitomycin C before the surgical excision of primary pterygium: clinical and histological results

open access: yesClinical Ophthalmology, 2017
Alahmady Hamad Alsmman,1 Gamal Radwan,1 Mortada Ahmed Abozaid,1 Usama Ali Mohammed,1 Nesreen Gamal Abd Elhaleim2 1Department of Ophthalmology, 2Department of Histology, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt Purpose: The aim of this ...
Alsmman AH   +4 more
doaj   +1 more source

A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients

open access: yesIndian Journal of Ophthalmology, 2015
Background: Pterygium is an ocular surface disorder with prevalence rates ranges from 0.3% to 29% in different parts of the world. Vascular endothelial growth factor (VEGF) has been detected in increased amounts in pterygium epithelium, compared with ...
Priyanka Singh   +3 more
doaj   +2 more sources

The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model [PDF]

open access: yesClinics, 2011
PURPOSE: To evaluate the use of subconjunctival bevacizumab on corneal neovascularization in an experimental rabbit model for its effect on vessel extension, inflammation, and corneal epithelialization.
Glauco Reggiani Mello   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy